0001882971-21-000001.txt : 20210924 0001882971-21-000001.hdr.sgml : 20210924 20210924145352 ACCESSION NUMBER: 0001882971-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210924 DATE AS OF CHANGE: 20210924 EFFECTIVENESS DATE: 20210924 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Garuda Therapeutics, Inc. CENTRAL INDEX KEY: 0001884363 IRS NUMBER: 863018867 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-414560 FILM NUMBER: 211277019 BUSINESS ADDRESS: STREET 1: 22 STRATHMORE ROAD STREET 2: SUITE 414 CITY: NATICK STATE: MA ZIP: 02467 BUSINESS PHONE: 617-851-4586 MAIL ADDRESS: STREET 1: 22 STRATHMORE ROAD STREET 2: SUITE 414 CITY: NATICK STATE: MA ZIP: 02467 D 1 primary_doc.xml X0708 D LIVE 0001884363 Garuda Therapeutics, Inc. 22 STRATHMORE ROAD SUITE 414 NATICK MA MASSACHUSETTS 01760 617-851-4586 DELAWARE L Stem, LLC None Corporation true 2021 Dhvanit I Shah c/o Garuda Therapeutics, Inc. 22 Strathmore Road, Suite 414 Natick MA MASSACHUSETTS 01760 Executive Officer Director Chief Executive Officer of the Issuer Eric Aguiar c/o Garuda Therapeutics, Inc. 22 Strathmore Road, Suite 414 Natick MA MASSACHUSETTS 01760 Director Carl Gordon c/o Garuda Therapeutics, Inc. 22 Strathmore Road, Suite 414 Natick MA MASSACHUSETTS 01760 Director Rahul Singhvi c/o Garuda Therapeutics, Inc. 22 Strathmore Road, Suite 414 Natick MA MASSACHUSETTS 01760 Director Shaan Gandhi c/o Garuda Therapeutics, Inc. 22 Strathmore Road, Suite 414 Natick MA MASSACHUSETTS 01760 Director Biotechnology Decline to Disclose 06b false 2021-09-09 false true false 0 Locust Walk Partners, LLC None Locust Walk Securities, LLC 156174 200 Clarendon Street 51st Floor Boston MA MASSACHUSETTS 02116 All States true 71790005 48123334 23666671 false 23 2000000 0 970000 true for founders loans, expense reimbursement and other contributions made by the Chief Executive Officer false Garuda Therapeutics, Inc. /s/ Dhvanit I. Shah Dhvanit I. Shah Chief Executive Officer 2021-09-24